Journal of the American Chemical Society,
Год журнала:
2025,
Номер
147(9), С. 7360 - 7376
Опубликована: Фев. 15, 2025
Hypoxia,
a
hallmark
of
many
solid
tumors,
is
linked
to
increased
cancer
aggressiveness,
metastasis,
and
resistance
conventional
therapies,
leading
poor
patient
outcomes.
This
challenges
the
efficiency
photodynamic
therapy
(PDT),
which
relies
on
generation
cytotoxic
reactive
oxygen
species
(ROS)
through
irradiation
photosensitizer
(PS),
process
partially
dependent
levels.
In
this
work,
we
introduce
novel
family
potent
PSs
based
ruthenium(II)
polypyridyl
complexes
with
2,2′-bipyridyl
ligands
derived
from
COUPY
coumarins,
termed
COUBPYs.
Ru-COUBPY
exhibit
outstanding
in
vitro
cytotoxicity
against
CT-26
cells
when
irradiated
light
within
phototherapeutic
window,
achieving
nanomolar
potency
both
normoxic
hypoxic
conditions
while
remaining
nontoxic
dark,
impressive
phototoxic
indices
(>30,000).
Their
ability
generate
Type
I
II
ROS
underpins
their
exceptional
PDT
efficiency.
The
lead
compound
study,
SCV49,
shows
favorable
vivo
pharmacokinetic
profile,
excellent
toxicological
tolerability,
tumor
growth
inhibition
mice
bearing
subcutaneous
tumors
at
doses
as
low
3
mg/kg
upon
deep-red
(660
nm).
These
results
allow
us
propose
SCV49
strong
candidate
for
further
preclinical
development,
particularly
treating
large
tumors.
Angewandte Chemie International Edition,
Год журнала:
2023,
Номер
62(15)
Опубликована: Фев. 14, 2023
Abstract
Although
metallacycle‐based
supramolecular
photosensitizers
(PSs)
have
attracted
increasing
attention
in
biomedicine,
their
clinical
translation
is
still
hindered
by
inherent
dark
toxicity.
Herein,
we
report
what
to
our
knowledge
the
first
example
of
a
molecular
engineering
approach
building
blocks
metallacycles
for
constructing
series
PSs
(
RuA–RuD
),
with
aim
simultaneously
reducing
toxicity
and
enhancing
phototoxicity,
consequently
obtaining
high
phototoxicity
indexes
(PI).
Detailed
vitro
investigations
demonstrate
that
display
cancer
cellular
uptake
remarkable
antitumor
activity
even
under
hypoxic
conditions.
Notably,
RuD
exhibited
no
displayed
highest
PI
value
(≈406).
Theoretical
calculations
verified
has
largest
steric
hindrance
lowest
singlet‐triplet
energy
gap
(Δ
E
ST
,
0.61
eV).
Further
vivo
studies
confirmed
allows
safe
effective
phototherapy
against
A549
tumors.
Angewandte Chemie International Edition,
Год журнала:
2023,
Номер
62(20)
Опубликована: Март 14, 2023
Five
osmium(II)
polypyridyl
complexes
of
the
general
formula
[Os(4,7-diphenyl-1,10-phenanthroline)2
L]2+
were
synthesized
as
photosensitizers
for
photodynamic
therapy
by
varying
nature
ligand
L.
Thanks
to
pronounced
π-extended
structure
ligands
and
heavy
atom
effect
provided
osmium
center,
these
exhibit
a
high
absorption
in
near-infrared
(NIR)
region
(up
740
nm),
unlike
related
ruthenium
complexes.
This
led
promising
phototoxicity
vitro
against
cancer
cells
cultured
2D
cell
layers
but
also
multicellular
tumor
spheroids
upon
irradiation
at
nm.
The
complex
(2,2'-bipyridine)]2+
was
found
be
most
efficient
various
lines,
with
indexes.
Experiments
on
CT26
tumor-bearing
BALB/c
mice
indicate
that
OsII
could
significantly
reduce
growth
following
nm
laser
irradiation.
biological
window
this
structurally
simple
makes
it
photosensitizer
treatment.
Multifunctional
phototheranostics
that
integrate
several
diagnostic
and
therapeutic
strategies
into
one
platform
hold
great
promise
for
precision
medicine.
However,
it
is
really
difficult
molecule
to
possess
multimodality
optical
imaging
therapy
properties
all
functions
are
in
the
optimized
mode
because
absorbed
photoenergy
fixed.
Herein,
a
smart
one-for-all
nanoagent
photophysical
energy
transformation
processes
can
be
facilely
tuned
by
external
light
stimuli
developed
precise
multifunctional
image-guided
therapy.
A
dithienylethene-based
designed
synthesized
has
two
light-switchable
forms.
In
ring-closed
form,
most
of
dissipates
via
nonradiative
thermal
deactivation
photoacoustic
(PA)
imaging.
ring-open
possesses
obvious
aggregation-induced
emission
features
with
excellent
fluorescence
photodynamic
properties.
vivo
experiments
demonstrate
preoperative
PA
help
delineate
tumors
high-contrast
manner,
intraoperative
able
sensitively
detect
tiny
residual
tumors.
Furthermore,
induce
immunogenic
cell
death
elicit
antitumor
immunity
significantly
suppress
solid
This
work
develops
agent
related
phototheranostic
light-driven
structure
switch,
which
promising
biomedical
applications.
Journal of Medicinal Chemistry,
Год журнала:
2023,
Номер
66(6), С. 4167 - 4178
Опубликована: Март 8, 2023
Two-photon
photodynamic
therapy
(TP-PDT),
as
a
new
method
for
cancer,
has
shown
unique
advantages
in
tumors.
A
low
two-photon
absorption
cross-section
(δ)
the
biologic
spectral
window
and
short
triplet
state
lifetime
are
important
issues
faced
by
current
photosensitizers
(PSs)
TP-PDT.
In
this
paper,
photophysical
properties
of
series
Ru(II)
complexes
were
studied
density
functional
theory
time-dependent
methods.
The
electronic
structure,
one-
properties,
type
I/II
mechanisms,
lifetime,
solvation
free
energy
calculated.
results
showed
that
substitution
methoxyls
pyrene
groups
greatly
improved
complex.
Furthermore,
addition
acetylenyl
subtly
enhanced
δ.
Overall,
complex
3b
possess
large
δ(1376
GM),
long
(136
μs),
better
energy.
It
is
hoped
it
can
provide
valuable
theoretical
guidance
design
synthesis
efficient
PSs
experiment.
International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
24(1), С. 689 - 689
Опубликована: Дек. 30, 2022
Ruthenium(II)–arene
complexes
have
gained
significant
research
interest
due
to
their
possible
application
in
cancer
therapy.
In
this
contribution
two
new
are
described,
namely
[{RuCl(η6-p-cymene)}2(μ-Cl)(μ-1-N,N′-naphthyl)]X
(X
=
Cl,
1;
PF6,
2),
which
were
fully
characterized
by
IR,
NMR,
and
elemental
microanalysis.
Furthermore,
the
structure
of
2
solid
state
was
determined
a
single
crystal
X-ray
crystallographic
study,
confirming
composition
crystals
as
2·2MeOH.
The
Hirshfeld
surface
analysis
employed
for
investigation
interactions
that
govern
structural
data
out
2·2MeOH
used
theoretical
cationic
part
[{RuCl(η6-p-cymene)}2(μ-Cl)(μ-1-N,N′-naphthyl)]+
(2a)
is
common
both
1
2.
density
functional
theory,
at
B3LYP/6-31+G(d,p)
basis
set
H,
C,
N,
Cl
atoms
LanL2DZ
Ru
ions,
optimization
2a
structure.
natural
bond
orbital
quantum
theory
molecules
analyses
quantify
intramolecular
interactions.
reproduction
experimental
IR
NMR
spectra
proved
applicability
chosen
level
theory.
binding
bovine
serum
albumin
examined
spectrofluorimetry
molecular
docking,
with
complementary
results
obtained.
Compound
acted
radical
scavenger
towards
DPPH•
HO•
radicals,
along
high
activity
prostate
colon
cell
lines.
Inorganic Chemistry,
Год журнала:
2023,
Номер
62(20), С. 7716 - 7727
Опубликована: Май 10, 2023
Ruthenium(II)
polypyridyl
complexes
(RPCs)
are
gaining
momentum
in
photoactivated
chemotherapy
(PACT),
thanks
to
the
possibility
of
overcoming
classical
reliance
on
molecular
oxygen
photodynamic
therapy
while
preserving
selective
drug
activation
by
using
light.
However,
notwithstanding
intriguing
perspectives,
translation
such
an
approach
development
new
antimicrobials
has
been
only
barely
considered.
Herein,
MTZH-1
and
MTZH-2,
two
novel
analogues
metronidazole
(MTZ),
a
mainstay
treatment
anaerobic
bacterial
infections,
were
designed
inserted
strained
ruthenium
[Ru(tpy)(dmp)(MTZ-1)]PF6
(Ru2)
[Ru(tpy)(dmp)(MTZ-2)]PF6
(Ru3)
(tpy
=
terpyridine,
dmp
2,9-dimethyl-1,10-phenanthroline)
(Chart
1).
Analogously
parental
compound
[Ru(tpy)(dmp)(5NIM)]PF6
(Ru1)
(5-nitroimidazolate),
Ru(II)-imidazolate
coordination
MTZ
derivatives
resulted
promising
Ru(II)
photocages,
capable
easily
unleash
bioactive
ligands
upon
light
irradiation
increase
antibacterial
activity
against
Bacillus
subtilis,
which
was
chosen
as
model
Gram-positive
bacteria.
The
photoreleased
5-nitroimidazole-based
led
remarkable
phototoxicities
under
hypoxic
conditions
(<1%
O2),
with
lead
Ru3
that
exhibited
highest
potency
across
series,
being
comparable
one
clinical
MTZ.
Besides,
chemical
architectures
made
their
interaction
NimAunfavorable,
NimA
reductases
responsible
for
resistance
antibiotics,
thus
hinting
at
possible
use
combat
antimicrobial
resistance.
This
work
may
therefore
provide
fundamental
knowledge
design
photoresponsive
tools
be
used
fight
infectious
diseases.
For
first
time,
effectiveness
"photorelease
therapy"
therapeutically
relevant
demonstrated.
Journal of Colloid and Interface Science,
Год журнала:
2024,
Номер
670, С. 234 - 245
Опубликована: Май 16, 2024
The
clinical
translation
of
photosensitizers
based
on
ruthenium(II)
polypyridyl
complexes
(RPCs)
in
photodynamic
therapy
cancer
faces
several
challenges.
To
address
these
limitations,
we
conducted
an
investigation
to
assess
the
potential
a
cubosome
formulation
stabilized
water
against
coalescence
utilizing
polyphosphoester
analog
Pluronic
F127
as
stabilizer
and
loaded
with
newly
synthesized
RPC-based
photosensitizer
[Ru(dppn)